ascompleteddrawing asac asian securities asad jumabhoy asafetida pill asagumo asahel brother of joa asahi asahi kasei emd asahi life insurance asahina mikuru asaki yumemi ji asakita-ku hiroshima asakusabashi area asami joh asami tanigushi asamoah gyan gyan asamskrta-dharmah asano k asano mizuho as...
Trial Registration ClinicalTrials.gov Identifier: NCT01782352 Introduction Age-related macular degeneration (AMD) is a chronic, progressive disease of the central retina and the leading cause of severe, irreversible vision loss in US adults.1 Most cases of severe vision loss are due to the advanced...
ArticlePubMedGoogle Scholar Buscher, A., Hartman, C., Kallen, M. A. & Giordano, T. P. Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients.Int. J. Std. Aids.23, 351–355 (2012). ArticleCASPubMedPubMed CentralGoog...
2006, 355: 1141-1153. 10.1056/NEJMsa060247. Article CAS PubMed Google Scholar Hontelez JA, De Vlas SJ, Tanser F, Bakker R, Barnighausen T, Newell ML, Baltussen R, Lurie MN: The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South ...
(clinicaltrials.gov identifier: NCT01593046) and their efficacy in patients (clinicaltrials.gov identifier: NCT02938520) that have achieved viral suppression with an integrase inhibitor-based single tablet regimen. DTG has also been shown to be effective as monotherapy or in combination with RPV for...